Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,886 | -18,335 | -8,428 | -23,342 | -15,875 |
| Depreciation Amortization | 1,149 | 874 | 556 | 341 | 93 |
| Accounts receivable | 185 | 532 | -120 | -695 | -963 |
| Accounts payable and accrued liabilities | 904 | 503 | 378 | 341 | 547 |
| Other Working Capital | 2,325 | 840 | -503 | 1,065 | -620 |
| Other Operating Activity | 618 | -152 | 176 | 3,229 | 3,365 |
| Operating Cash Flow | $-23,705 | $-15,738 | $-7,941 | $-19,061 | $-13,453 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -141 | -107 | -29 | -185 | -76 |
| Other Investing Activity | -230 | -230 | 0 | 0 | 0 |
| Investing Cash Flow | $-371 | $-337 | $-29 | $-185 | $-76 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 8,500 | N/A |
| Debt Issued | 15,000 | 15,000 | 15,000 | N/A | 8,500 |
| Debt Repayment | -3,921 | -3,921 | -3,921 | -3,348 | -2,486 |
| Common Stock Issued | 39,813 | 39,657 | 2,411 | 60,002 | 60,001 |
| Other Financing Activity | -359 | -359 | -378 | -222 | -188 |
| Financing Cash Flow | $50,533 | $50,377 | $13,112 | $64,932 | $65,827 |
| Beginning Cash Position | 51,174 | 51,174 | 51,174 | 5,488 | 5,488 |
| End Cash Position | 77,631 | 85,476 | 56,316 | 51,174 | 57,786 |
| Net Cash Flow | $26,457 | $34,302 | $5,142 | $45,686 | $52,298 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,705 | -15,738 | -7,941 | -19,061 | -13,453 |
| Capital Expenditure | -141 | -107 | -29 | -225 | -116 |
| Free Cash Flow | -23,846 | -15,845 | -7,970 | -19,286 | -13,569 |